Search Within

Kelly Leigh Bolton

  1. "Early Drug Development Service"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. Early Drug Development Service (7)
  4. Hematologic Malignancies, Division of (7)
  5. Solid Tumor Oncology Division (7)
  6. Weinberg Fellows (7)

More Groups

People
  1. Ahmet Zehir (7)
  2. David Hyman (7)
  3. Michael Berger (6)
  4. Ross Levine (6)
  5. Ryan Ptashkin (6)
  6. Elli Papaemmanuil (5)

More People

Years
  1. 2020 (3)
  2. 2019 (2)
  3. 2018 (2)
Publications
  1. Blood (2)
  2. Cancer Research (2)
  3. JAMA Oncology (1)
  4. Journal of Clinical Oncology (1)
  5. Nature Genetics (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Hematology (2)
  3. American Medical Association (1)
  4. American Society of Clinical Oncology (1)
  5. Nature Publishing Group (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis
    Journal Article

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Kelly, D.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Moukarzel, L. A.; Ptashkin, R.; Gao, T.; Patel, M.; Caltabellotta, N.; Braunstein, L. Z.; Aghajanian, C.; Hyman, D. M.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Extended mutational profiling by MSK-IMPACT™ identifies mutations predicting thromboembolic risk in patients with solid tumor malignancy
    Meeting Abstract

    Dunbar, A.; Bolton, K.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J. M.; Kelly, D.; Farina, M.; Kishore, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors
    Journal Article

    Ptashkin, R. N.; Mandelker, D. L.; Coombs, C. C.; Bolton, K.; Yelskaya, Z.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save